Opinion

Latest News

The Value in Committing to Conscientious Corporate Stewardship
The Value in Committing to Conscientious Corporate Stewardship

August 7th 2024

Why it is important for organizations to set long-term goals when planning for a sustainable future?

Driving CAR-Ts for Treatment in Cancer and Immunology
Driving CAR-Ts for Treatment in Cancer and Immunology

July 24th 2024

Improving Cross-Industry Collaboration on Drug Discount Programs
Improving Cross-Industry Collaboration on Drug Discount Programs

July 17th 2024

Public Sentiments Toward Purchasing Foreign Vaccines During a Pandemic
Public Sentiments Toward Purchasing Foreign Vaccines During a Pandemic

June 7th 2024

The Impact of Serialization Technology: Ensuring Product Integrity and Regulatory Compliance
The Impact of Serialization Technology: Ensuring Product Integrity and Regulatory Compliance

May 30th 2024

More News

Site Logo

No surprise here: FDA drug oversight is now a 'high risk' government operation

Nicholas Basta
February 19th 2009

FDA’s management of drug and device safety enters GAO’s biennial watch list

Site Logo

Leading in Challenging Times

Ross Bjella, DDN
February 18th 2009

It has been said that one should never miss an opportunity to make the most of a crisis. The steady stream of headlines announcing staff cuts, delays in drug approvals and a narrowing of R&D focus for pharmaceutical and biotech companies indicate there will be no shortage of opportunities in 2009.

Site Logo

Specialty Pharmaceuticals and the Emergence of Sub-Specialty Pharmacy

Dean Erhardt, MBA, D2 Pharma Consulting LLC
February 18th 2009

‘Ultra-orphan’ diseases will alter the specialty distribution process

<1
...
56789
© 2024 MJH Life Sciences

All rights reserved.